Comorbidities associated with early chronickidney disease among young people living withHIV in Uganda. A nested case control study

Read full text
Authors: Esther M Nasuuna, Laurie A. Tomlinson, Robert Kalyesubula, Barbara Castelnuovo, Nicholus Nanyeenya, Chido Dziva Chikwari, Helen Anne Weiss
Cited by: 0
References: 34

Abstract

INTRODUCTION: Chronic kidney disease (CKD) is often complicated by disorders in multiple body systems, associated with higher mortality and morbidity. Young people living with HIV (YPLHIV) have an increased risk of multisystem chronic comorbidities. However, there are few data describing comorbidities associated with CKD among YPLHIV. METHODS: We conducted a case-control study in seven ART clinics in Kampala, Uganda. Cases were YPLHIV (aged 10–24 years) diagnosed with CKD and controls were those without CKD. We collected data on demographic and clinical factors: HIV viral load, CD4 T cell count, blood pressure, fasting glucose levels, anaemia, electrolytes, parathyroid hormone, and cognitive impairment. We summarized the demographic and clinical factors and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals for associations between CKD comorbidities, adjusted for age, sex and viral suppression. RESULTS: A total of 292 participants (96 cases and 196 controls) were recruited. Cases were mostly male (59.4% vs. 36.5%), and younger (88.5% vs. 46.4% aged < 17 years) compared to controls. CKD was associated with having a detectable HIV viral load (OR = 3.73; 95% CI 1.53–9.12) and proteinuria (aOR = 4.19; 95% CI 2.28–7.72). CKD was also associated with low haematocrit, hypochloraemia, hyperphosphatemia, and high mean corpuscular volume. There was no evidence of an association of CKD with hypertension, anaemia, or stunting. CONCLUSION: The pattern of comorbidities among YPLHIV with CKD is uncertain and difficulties may relate to difficulty determining true kidney function and normal ranges in this population. Further studies are needed to discern the pattern of CKD complications to improve management efforts and clinical outcomes. CLINICAL TRIAL NUMBER: Not applicable.

Fields of Study & Subjects

HIV-related health complications and treatments HIV/AIDS Research and Interventions Chronic Kidney Disease and Diabetes

Publication details

Journal / source
BMC Nephrology
Volume
27
Issue
1
Pages
108–108
Publication date
16 January 2026
Language
EN